Webb24 mars 2024 · InMed Pharmaceuticals Inc. ist ein pharmazeutisches Unternehmen in der klinischen Phase, das sich mit der Entwicklung, Herstellung und Vermarktung von seltenen Cannabinoiden beschäftigt. Webb19 apr. 2024 · InMed is also a clinical-stage company developing a pipeline of rare cannabinoid therapeutics and dedicated to delivering new treatment alternatives to …

2024-06-09 NDAQ:INM Press Release InMed Pharmaceuticals Inc.

http://www.wikicfp.com/cfp/servlet/event.showcfp?eventid=169665 Webb27 apr. 2024 · InMed’s common shares will continue to be listed and traded on Nasdaq and its Canadian shareholders’ existing shares will trade through their brokers on the Nasdaq stock exchange. InMed... horsevisual

About INMED University of North Dakota

Webb31 dec. 2024 · About InMed: InMed Pharmaceuticals is a global leader in the manufacturing and development of rare cannabinoids. Together with our subsidiary, … Webb13 sep. 2024 · InMed Pharmaceuticals (NASDAQ: INM) is looking to acquire one of its competitors. The firm has entered into a definitive agreement to acquire BayMedica Inc, a specialty firm focused on manufacturing and commercializing cannabinoids. Webb8 apr. 2024 · INM Stock Overview InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products. About the company Risk Analysis Earnings have declined by 20.5% per year over past 5 years Has less than 1 year of cash runway Highly volatile share price over the past 3 months pspax dividend history